These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30541891)

  • 1. DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network.
    Hamdan FH; Johnsen SA
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12343-E12352. PubMed ID: 30541891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas.
    Wang X; Kutschat AP; Yamada M; Prokakis E; Böttcher P; Tanaka K; Doki Y; Hamdan FH; Johnsen SA
    Cell Death Differ; 2021 Jul; 28(7):2207-2220. PubMed ID: 33658703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma.
    Maia-Silva D; Cunniff PJ; Schier AC; Skopelitis D; Trousdell MC; Moresco P; Gao Y; Kechejian V; He XY; Sahin Y; Wan L; Alpsoy A; Liverpool J; Krainer AR; Egeblad M; Spector DL; Fearon DT; Dos Santos CO; Taatjes DJ; Vakoc CR
    Nat Genet; 2024 Jul; 56(7):1377-1385. PubMed ID: 38886586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors.
    Andricovich J; Perkail S; Kai Y; Casasanta N; Peng W; Tzatsos A
    Cancer Cell; 2018 Mar; 33(3):512-526.e8. PubMed ID: 29533787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes.
    Lomberk G; Blum Y; Nicolle R; Nair A; Gaonkar KS; Marisa L; Mathison A; Sun Z; Yan H; Elarouci N; Armenoult L; Ayadi M; Ordog T; Lee JH; Oliver G; Klee E; Moutardier V; Gayet O; Bian B; Duconseil P; Gilabert M; Bigonnet M; Garcia S; Turrini O; Delpero JR; Giovannini M; Grandval P; Gasmi M; Secq V; De Reyniès A; Dusetti N; Iovanna J; Urrutia R
    Nat Commun; 2018 May; 9(1):1978. PubMed ID: 29773832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ΔNp63 bookmarks and creates an accessible epigenetic environment for TGFβ-induced cancer cell stemness and invasiveness.
    Vasilaki E; Bai Y; Ali MM; Sundqvist A; Moustakas A; Heldin CH
    Cell Commun Signal; 2024 Aug; 22(1):411. PubMed ID: 39180088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ΔNp63-restricted viral mimicry response impedes cancer cell viability and remodels tumor microenvironment in esophageal squamous cell carcinoma.
    Yu VZ; So SS; Lung BC; Hou GZ; Wong CW; Chow LK; Chung MK; Wong IY; Wong CL; Chan DK; Chan FS; Law BT; Xu K; Tan ZZ; Lam KO; Lo AW; Lam AK; Kwong DL; Ko JM; Dai W; Law S; Lung ML
    Cancer Lett; 2024 Jul; 595():216999. PubMed ID: 38823762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma.
    Bretz AC; Gittler MP; Charles JP; Gremke N; Eckhardt I; Mernberger M; Mandic R; Thomale J; Nist A; Wanzel M; Stiewe T
    Nucleic Acids Res; 2016 Apr; 44(7):3204-18. PubMed ID: 26819410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and cellular validation of prognostic genes regulated by super enhancers in oral squamous cell carcinoma.
    Zhang L; Li H; Qiu Y; Liu Y; Liu X; Wang W
    Bioengineered; 2021 Dec; 12(2):10073-10088. PubMed ID: 34709988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment.
    Gatti V; Fierro C; Annicchiarico-Petruzzelli M; Melino G; Peschiaroli A
    Mol Oncol; 2019 May; 13(5):981-1001. PubMed ID: 30845357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.
    Jiang Y; Jiang YY; Xie JJ; Mayakonda A; Hazawa M; Chen L; Xiao JF; Li CQ; Huang ML; Ding LW; Sun QY; Xu L; Kanojia D; Jeitany M; Deng JW; Liao LD; Soukiasian HJ; Berman BP; Hao JJ; Xu LY; Li EM; Wang MR; Bi XG; Lin DC; Koeffler HP
    Nat Commun; 2018 Sep; 9(1):3619. PubMed ID: 30190462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal Regulation of ΔNp63 by TGFβ-Regulated miRNAs Is Essential for Cancer Metastasis.
    Bui NHB; Napoli M; Davis AJ; Abbas HA; Rajapakshe K; Coarfa C; Flores ER
    Cancer Res; 2020 Jul; 80(13):2833-2847. PubMed ID: 32312834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma.
    Somerville TDD; Xu Y; Miyabayashi K; Tiriac H; Cleary CR; Maia-Silva D; Milazzo JP; Tuveson DA; Vakoc CR
    Cell Rep; 2018 Nov; 25(7):1741-1755.e7. PubMed ID: 30428345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ΔNp63-MED12 axis drives basal-like identity in pancreatic cancer.
    Nat Genet; 2024 Jul; 56(7):1331-1332. PubMed ID: 38956209
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
    Franco HL; Nagari A; Malladi VS; Li W; Xi Y; Richardson D; Allton KL; Tanaka K; Li J; Murakami S; Keyomarsi K; Bedford MT; Shi X; Li W; Barton MC; Dent SYR; Kraus WL
    Genome Res; 2018 Feb; 28(2):159-170. PubMed ID: 29273624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ΔNp63 isoform-mediated β-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma.
    Suarez-Carmona M; Hubert P; Gonzalez A; Duray A; Roncarati P; Erpicum C; Boniver J; Castronovo V; Noel A; Saussez S; Peulen O; Delvenne P; Herfs M
    Oncotarget; 2014 Apr; 5(7):1856-68. PubMed ID: 24732135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression.
    Ruptier C; De Gaspéris A; Ansieau S; Granjon A; Tanière P; Lafosse I; Shi H; Petitjean A; Taranchon-Clermont E; Tribollet V; Voeltzel T; Scoazec JY; Maguer-Satta V; Puisieux A; Hainaut P; Cavard C; Caron de Fromentel C
    Oncogene; 2011 Nov; 30(46):4656-65. PubMed ID: 21643019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.